CAPZA completed the acquisition of a minority stake in Biolam from Gimv.

Synopsis

CAPZA, a private investment platform, completed the acquisition of a minority stake in Biolam, a consolidation platform for medical biology laboratories, from Gimv, a private equity firm. Financial terms were not disclosed.

Principals

target

Groupe Biolam

bidder

CAPZA

Show Details & Financials

Did you work on this deal?

Claim Deal

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Claim Deal

Market Context